June 9, 2026 Trifluridine/Tipiracil Fails to Improve Disease-Free Survival in ctDNA-Positive Resected Colorectal Cancer: ALTAIR Phase 3 Trial Results
June 9, 2026 Tirzepatide + Apitegromab Preserves Lean Mass Better Than Tirzepatide + Placebo in Phase 2 EMBRAZE Study
June 8, 2026 Retrospective Analysis Suggests Electronic Cigarettes Post-Quit Smoking Increase Lung Cancer Risk
June 6, 2026 Inflammation as a Hidden Driver of Cardiovascular Risk: AI Scans and Immunotherapy Breakthroughs
